CLINICAL TRIALS PROFILE FOR PRAMLINTIDE ACETATE
✉ Email this page to a colleague
All Clinical Trials for pramlintide acetate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00042458 ↗ | Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control | Completed | AstraZeneca | Phase 3 | 2002-04-01 | This is a randomized, triple-blind, placebo-controlled, multicenter study to investigate the safety of pramlintide treatment using pramlintide dose-titration coupled with insulin adjustments in subjects with type 1 diabetes who are actively trying to improve their glycemic control. |
| NCT00042471 ↗ | Evaluation of the Bioavailability of Pramlintide | Completed | AstraZeneca | Phase 2 | 2002-06-01 | This is a randomized, open-label, crossover study to examine the bioavailability of pramlintide in normal weight and overweight subjects with type 1 and type 2 diabetes mellitus using insulin. |
| NCT00042601 ↗ | Evaluation of the Effect of Pramlintide on Satiety and Food Intake | Completed | AstraZeneca | Phase 2 | 2002-07-01 | This is a single center, randomized, blinded, placebo-controlled, two-period, cross-over study to evaluate the effect of pramlintide on satiety and food intake in normal-weight and obese non-diabetic subjects and in insulin-treated subjects with type 1 and type 2 diabetes. |
| NCT00044707 ↗ | Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide | Completed | AstraZeneca | Phase 2 | 2002-08-01 | This is a randomized, single-blind, placebo-controlled, crossover study to examine the effect of pramlintide on the pharmacokinetics of an orally administered medication |
| NCT00107107 ↗ | Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus | Completed | AstraZeneca | Phase 3 | 2002-11-01 | This is a multicenter, open-label extension study designed to examine the long-term safety of pramlintide treatment in subjects with type 1 diabetes who have successfully completed treatment in the parent study 137-150. |
| NCT00108004 ↗ | Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus | Completed | AstraZeneca | Phase 3 | 2003-04-01 | This open-label, multicenter study is designed to investigate the clinical utility and safety of pramlintide treatment in subjects with type 1 and type 2 diabetes who are failing to achieve the desired level of glycemic control using insulin therapy. |
| NCT00112021 ↗ | A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects | Completed | AstraZeneca | Phase 2 | 2005-05-01 | This is a study to examine the effect of pramlintide on body weight and its safety and tolerability in obese subjects. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for pramlintide acetate
Condition Name
Clinical Trial Locations for pramlintide acetate
Trials by Country
Clinical Trial Progress for pramlintide acetate
Clinical Trial Phase
Clinical Trial Sponsors for pramlintide acetate
Sponsor Name
